429 related articles for article (PubMed ID: 9403477)
1. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group.
Ann Neurol; 1997 Dec; 42(6):857-65. PubMed ID: 9403477
[TBL] [Abstract][Full Text] [Related]
2. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
[TBL] [Abstract][Full Text] [Related]
3. Bleeding increases the risk of ischemic events in patients with peripheral arterial disease.
van Hattum ES; Algra A; Lawson JA; Eikelboom BC; Moll FL; Tangelder MJ
Circulation; 2009 Oct; 120(16):1569-76. PubMed ID: 19805650
[TBL] [Abstract][Full Text] [Related]
4. [No role for oral anticoagulants (target INR: 2.0-3.0) after transient ischaemic attack or cerebral infarction of arterial origin; the 'European/Australasian stroke prevention in reversible ischaemia trial' (ESPRIT)].
De Schryver EL; Halkes PH
Ned Tijdschr Geneeskd; 2008 Feb; 152(8):445-53. PubMed ID: 18361194
[TBL] [Abstract][Full Text] [Related]
5. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
[TBL] [Abstract][Full Text] [Related]
6. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
7. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients.
Georgiadis D; Arnold M; von Buedingen HC; Valko P; Sarikaya H; Rousson V; Mattle HP; Bousser MG; Baumgartner RW
Neurology; 2009 May; 72(21):1810-5. PubMed ID: 19321846
[TBL] [Abstract][Full Text] [Related]
8. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
; Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C; Crowell R; Keltai M; Gosselin G
N Engl J Med; 2007 Jul; 357(3):217-27. PubMed ID: 17634457
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
Pérez-Gómez F; Alegría E; Berjón J; Iriarte JA; Zumalde J; Salvador A; Mataix L;
J Am Coll Cardiol; 2004 Oct; 44(8):1557-66. PubMed ID: 15489085
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of vascular complications following cerebral ischemia of arterial origin; the ESPRIT trial: mild anticoagulant therapy, combination treatment with acetylsalicylic acid plus dipyridamole or treatment with acetylsalicylic acid alone?].
Gorter JW; De Schryver EL; Algra A
Ned Tijdschr Geneeskd; 1998 Feb; 142(6):316-8. PubMed ID: 9562733
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
[TBL] [Abstract][Full Text] [Related]
12. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.
Chimowitz MI; Lynn MJ; Howlett-Smith H; Stern BJ; Hertzberg VS; Frankel MR; Levine SR; Chaturvedi S; Kasner SE; Benesch CG; Sila CA; Jovin TG; Romano JG;
N Engl J Med; 2005 Mar; 352(13):1305-16. PubMed ID: 15800226
[TBL] [Abstract][Full Text] [Related]
13. Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.
Arjomand H; Cohen M; Ezekowitz MD
J Invasive Cardiol; 2004 May; 16(5):271-8. PubMed ID: 15152137
[TBL] [Abstract][Full Text] [Related]
14. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
[TBL] [Abstract][Full Text] [Related]
15. Intravenously administered acetylsalicylic acid in combination with low-dose heparin in acute ischemic stroke: a safety analysis.
Büttner T; Hellwig K; Müller T; Kuhn W
Clin Neuropharmacol; 1998; 21(1):48-51. PubMed ID: 9579285
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient?
Halkes PH; Algra A
Cerebrovasc Dis; 2007; 24 Suppl 1():107-11. PubMed ID: 17971645
[TBL] [Abstract][Full Text] [Related]
17. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
Lutsep HL
J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic drugs for the secondary prevention of ischemic stroke.
Nenci GG; Goracci S
Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
[TBL] [Abstract][Full Text] [Related]
19. Effects of aspirin or picotamide, an antithromboxane agent, in combination with low-intensity oral anticoagulation in patients with acute myocardial infarction: a controlled randomized pilot trial.
Vetrano A; Milani M; Corsini G
G Ital Cardiol; 1999 May; 29(5):524-8. PubMed ID: 10367219
[TBL] [Abstract][Full Text] [Related]
20. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]